Tirzepatide also reduced hypoxic load, high-sensitivity CRP, and systolic blood pressure
High biotin levels can cause falsely low TSH readings and falsely elevated free T4, mimicking hyperthyroidism on paper
Zepbound can be expensive but may be covered by insurance
Compound Receptors Peak trial weight loss Lean mass as share of loss Semaglutide (Ozempic/Wegovy) GLP-1 ~14.9% (STEP-1, 68 wk) ~39% Tirzepatide (Mounjaro/Zepbound) GLP-1 + GIP ~20.9% (SURMOUNT-1, 72 wk) ~25-40% Retatrutide GLP-1 + GIP + GCGR ~24.2% (Phase 2, 48 wk) Comparable class range Best for understanding the takeaway: the percentage of loss that is lean mass is roughly constant across the class
While each case is unique, compensation often covers: Medical expenses (past and future) Lost wages and diminished earning capacity Pain and suffering Loss of quality of life The amount of compensation varies based on several factors, including the severity of vision damage, its impact on daily life and ability to work, the age of the patient, and the long-term prognosis
